2.72
price up icon4.21%   0.11
pre-market  Pre-mercato:  3.28   0.56   +20.59%
loading
Precedente Chiudi:
$2.61
Aprire:
$2.648
Volume 24 ore:
434.90K
Relative Volume:
0.24
Capitalizzazione di mercato:
$101.79M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-1.45%
1M Prestazione:
-32.84%
6M Prestazione:
-42.86%
1 anno Prestazione:
+0.00%
Intervallo 1D:
Value
$2.55
$2.74
Intervallo di 1 settimana:
Value
$2.55
$2.97
Portata 52W:
Value
$1.61
$12.74

Metagenomi Inc Stock (MGX) Company Profile

Name
Nome
Metagenomi Inc
Name
Telefono
(510) 871-4880
Name
Indirizzo
5959 HORTON STREET, EMERYVILLE
Name
Dipendente
207
Name
Cinguettio
Name
Prossima data di guadagno
Name
Ultimi documenti SEC
Name
MGX's Discussions on Twitter

Confronta MGX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
MGX
Metagenomi Inc
2.72 101.79M 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
427.89 110.19B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
687.80 75.58B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
647.39 38.71B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
264.99 34.18B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
117.25 28.11B 3.30B -501.07M 1.03B -2.1146

Metagenomi Inc Stock (MGX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-05-07 Iniziato H.C. Wainwright Buy
2024-05-02 Downgrade JP Morgan Overweight → Neutral
2024-03-05 Iniziato BMO Capital Markets Outperform
2024-03-05 Iniziato Chardan Capital Markets Buy
2024-03-05 Iniziato JP Morgan Overweight
2024-03-05 Iniziato Jefferies Buy
2024-03-05 Iniziato TD Cowen Outperform
2024-03-05 Iniziato Wells Fargo Overweight
Mostra tutto

Metagenomi Inc Borsa (MGX) Ultime notizie

pulisher
Jan 21, 2025

Metagenomi aiming for clinical trials of gene-editing therapy in 2026 - Hemophilia News Today

Jan 21, 2025
pulisher
Jan 18, 2025

Metagenomi outlines anticipated 2025 milestones - MSN

Jan 18, 2025
pulisher
Jan 16, 2025

Metagenomi advances gene editing therapies into 2025 - Investing.com

Jan 16, 2025
pulisher
Jan 16, 2025

Metagenomi Highlights Progress Across Therapeutic Portfolio and Outlines Anticipated Milestones - GlobeNewswire

Jan 16, 2025
pulisher
Jan 16, 2025

Metagenomi Reports 16-Month Breakthrough in Hemophilia A Treatment Development Program - StockTitan

Jan 16, 2025
pulisher
Jan 15, 2025

Metagenomi Announces New Appointment to its Board of Directors - GlobeNewswire

Jan 15, 2025
pulisher
Jan 15, 2025

Metagenomi, Inc. Announces Appointment of Eric Bjerkholt to Its Board of Directors, Serving on Audit and Compensation Committees, Effective January 27, 2025 - Marketscreener.com

Jan 15, 2025
pulisher
Jan 15, 2025

Metagenomi, Inc.'s (NASDAQ:MGX) market cap dropped US$12m last week; individual investors who hold 33% were hit as were institutions - Yahoo Finance

Jan 15, 2025
pulisher
Jan 14, 2025

We Think Metagenomi (NASDAQ:MGX) Needs To Drive Business Growth Carefully - Simply Wall St

Jan 14, 2025
pulisher
Jan 13, 2025

Class Action Lawsuit Against Metagenomi Inc. (NASDAQ:MGX) - MSN

Jan 13, 2025
pulisher
Jan 12, 2025

Geode Capital Management LLC Has $734,000 Position in Metagenomi, Inc. (NASDAQ:MGX) - Defense World

Jan 12, 2025
pulisher
Jan 08, 2025

Metagenomi to Present at the 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times

Jan 08, 2025
pulisher
Jan 08, 2025

Metagenomi CEO to Present at J.P. Morgan Healthcare Conference 2025 - StockTitan

Jan 08, 2025
pulisher
Dec 30, 2024

Metagenomi, Inc. (NASDAQ:MGX) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat

Dec 30, 2024
pulisher
Dec 30, 2024

Metagenomi, Inc. (NASDAQ:MGX) Given Consensus Rating of “Moderate Buy” by Brokerages - Defense World

Dec 30, 2024
pulisher
Dec 28, 2024

Metagenomi: Q3 Earnings Snapshot - Marketscreener.com

Dec 28, 2024
pulisher
Dec 26, 2024

Metagenomi, Inc. (NASDAQ:MGX) Short Interest Up 445.1% in December - MarketBeat

Dec 26, 2024
pulisher
Dec 21, 2024

Metagenomi, Inc. (NASDAQ:MGX) Shares Purchased by BNP Paribas Financial Markets - Defense World

Dec 21, 2024
pulisher
Dec 18, 2024

Verition Fund Management LLC Makes New Investment in Metagenomi, Inc. (NASDAQ:MGX) - Defense World

Dec 18, 2024
pulisher
Dec 14, 2024

Levi & Korsinsky Reminds Metagenomi Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 25, 2024MGX - The Eastern Progress Online

Dec 14, 2024
pulisher
Dec 13, 2024

MGX INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $00,000 In MGX To Contact Him Directly To Discuss Their Options - The Eastern Progress Online

Dec 13, 2024
pulisher
Dec 13, 2024

2 ‘Monster’ Stocks to Snap Up Before 2025 - MSN

Dec 13, 2024
pulisher
Dec 13, 2024

Metagenomi (NASDAQ:MGX) Price Target Raised to $14.00 - Defense World

Dec 13, 2024
pulisher
Dec 13, 2024

MGX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Metagenomi, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - The Eastern Progress Online

Dec 13, 2024
pulisher
Dec 12, 2024

Structure Therapeutics Inc (GPCR-Q) QuotePress Release - The Globe and Mail

Dec 12, 2024
pulisher
Dec 12, 2024

2 ‘Monster’ Stocks To Snap Up Before 2025 - Barchart

Dec 12, 2024
pulisher
Dec 12, 2024

Shareholders of Metagenomi, Inc. Should Contact The Gross Law Firm Before November 25, 2024 to Discuss Your RightsMGX - The Eastern Progress Online

Dec 12, 2024
pulisher
Dec 11, 2024

Metagenomi Presents Highly Specific and Efficient Genome Editing Tools at Nature Conference 'RNA at the Bench and Bedside IV” - The Manila Times

Dec 11, 2024
pulisher
Dec 11, 2024

Metagenomi Presents Highly Specific and Efficient Genome - GlobeNewswire

Dec 11, 2024
pulisher
Dec 11, 2024

Metagenomi, Inc. Presents Highly Specific and Efficient Genome Editing Tools At Nature Conference RNA At the Bench and Bedside IV - Marketscreener.com

Dec 11, 2024
pulisher
Dec 11, 2024

Metagenomi, Inc. Sued for Securities Law ViolationsInvestors Should Contact The Gross Law Firm Before November 25, 2024 to Discuss Your RightsMGX - The Eastern Progress Online

Dec 11, 2024
pulisher
Dec 11, 2024

MGX Investors Have Opportunity to Lead Metagenomi, Inc. Securities Fraud Lawsuit with the Schall Law Firm - The Eastern Progress Online

Dec 11, 2024
pulisher
Dec 10, 2024

Expert Outlook: Metagenomi Through The Eyes Of 4 Analysts - Benzinga

Dec 10, 2024
pulisher
Dec 10, 2024

Metagenomi (NASDAQ:MGX) Stock Price Expected to Rise, HC Wainwright Analyst Says - MarketBeat

Dec 10, 2024
pulisher
Dec 10, 2024

Metagenomi presents updated preclinical NHP data at ASH meeting - TipRanks

Dec 10, 2024
pulisher
Dec 10, 2024

Metagenomi, Inc. (NASDAQ:MGX) Stock Catapults 106% Though Its Price And Business Still Lag The Industry - Simply Wall St

Dec 10, 2024
pulisher
Dec 09, 2024

Metagenomi presents updated preclinical data in Hemophilia A at ASH - TipRanks

Dec 09, 2024
pulisher
Dec 09, 2024

Metagenomi's Gene Therapy Shows Breakthrough 16-Month Durability in Hemophilia A Preclinical Data - StockTitan

Dec 09, 2024
pulisher
Dec 09, 2024

Metagenomi Presents Updated Preclinical Data in Hemophilia A at American Society of Hematology (ASH) 66th Annual Meeting - Yahoo Finance

Dec 09, 2024
pulisher
Dec 09, 2024

Metagenomi Presents Updated Preclinical Data in Hemophilia A at American Society of Hematology (ASH) 66th - EIN News

Dec 09, 2024
pulisher
Dec 08, 2024

MGX Investors Have Opportunity to Lead Metagenomi, Inc. Securities Lawsuit - The Eastern Progress Online

Dec 08, 2024
pulisher
Dec 08, 2024

Jefferies Predicts Up to ~1000% Surge for These 2 ‘Strong Buy’ Stocks - Yahoo Finance

Dec 08, 2024
pulisher
Dec 07, 2024

Shareholders that lost money on Metagenomi, Inc.(MGX) Urged to Join Class ActionContact The Gross Law Firm to Learn More - The Eastern Progress Online

Dec 07, 2024
pulisher
Dec 07, 2024

MGX Investors Have Opportunity to Lead Metagenomi, Inc. Securities Fraud Lawsuit - The Eastern Progress Online

Dec 07, 2024
pulisher
Dec 07, 2024

Lawsuit Deadline Notice: Metagenomi, Inc. Investors who lost over $100,000 with NASDAQ: MGX shares should contact the Shareholders Foundation - The Eastern Progress Online

Dec 07, 2024

Metagenomi Inc Azioni (MGX) Dati Finanziari

Non sono disponibili dati finanziari per Metagenomi Inc (MGX). Controlla altri titoli per ulteriori informazioni.

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$21.80
price up icon 4.81%
$73.47
price up icon 2.14%
$22.10
price up icon 16.13%
$367.97
price up icon 2.52%
biotechnology ONC
$218.70
price up icon 4.10%
$117.25
price up icon 4.75%
Capitalizzazione:     |  Volume (24 ore):